Go Ad-Free
logoThe People's Perspective on Medicine

Actos and Bladder Cancer

A commonly prescribed diabetes drug called Actos (pioglitazone) has been linked to an increased risk of bladder cancer. A year ago the Food and Drug Administration issued a warning that this drug might raise a person’s chance of developing bladder cancer. Now researchers have found data that confirm this concern.
The investigators reviewed records from more than 60,000 people with type 2 diabetes in the United Kingdom. Those who took Actos were two to three times more likely to be diagnosed with bladder cancer compared to those taking other antidiabetes drugs. Although the drug was banned in France and Germany last year, it remains a popular treatment in the United States.
[Journal of the National Cancer Institute, online Aug. 9, 2012]

Rate this article
0- 0 ratings
About the Author
Terry Graedon, PhD, is a medical anthropologist and co-host of The People’s Pharmacy radio show, co-author of The People’s Pharmacy syndicated newspaper columns and numerous books, and co-founder of The People’s Pharmacy website. Terry taught in the Duke University School of Nursing and was an adjunct assistant professor in the Department of Anthropology. She is a Fellow of the Society of Applied Anthropology. Terry is one of the country's leading authorities on the science behind folk remedies..
Tired of the ads on our website?

Now you can browse our website completely ad-free for just $5 / month. Stay up to date on breaking health news and support our work without the distraction of advertisements.

Browse our website ad-free
Join over 150,000 Subscribers at The People's Pharmacy

We're empowering you to make wise decisions about your own health, by providing you with essential health information about both medical and alternative treatment options.